KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Operating Expenses: 2009-2024

Historic Operating Expenses for Ionis Pharmaceuticals (IONS) over the last 16 years, with Dec 2024 value amounting to $1.2 billion.

  • Ionis Pharmaceuticals' Operating Expenses rose 12.19% to $316.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 6.10%. This contributed to the annual value of $1.2 billion for FY2024, which is 3.40% up from last year.
  • As of FY2024, Ionis Pharmaceuticals' Operating Expenses stood at $1.2 billion, which was up 3.40% from $1.1 billion recorded in FY2023.
  • In the past 5 years, Ionis Pharmaceuticals' Operating Expenses ranged from a high of $1.2 billion in FY2024 and a low of $840.6 million during FY2021.
  • Its 3-year average for Operating Expenses is $1.1 billion, with a median of $1.1 billion in 2023.
  • In the last 5 years, Ionis Pharmaceuticals' Operating Expenses increased by 19.11% in 2020 and then fell by 6.73% in 2021.
  • Ionis Pharmaceuticals' Operating Expenses (Yearly) stood at $901.3 million in 2020, then declined by 6.73% to $840.6 million in 2021, then grew by 18.67% to $997.6 million in 2022, then grew by 14.42% to $1.1 billion in 2023, then grew by 3.40% to $1.2 billion in 2024.